Darko Skegro, PhDDirector and Site Head, Biotherapeutic Engineering and Conjugation at NovartisSpeaker
Agenda Sessions
Engineering IgA/IgG Recruiters to Leverage Myeloid Cells in Cancer Immunotherapy
, 09:00View Session
